J. A. Cohen

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations

Pharmacy, Neurology, Pharmacotherapy +15

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1998 · 512 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

Bruce Cree, Omar Khan, Dennis Bourdette et al. · Neurology · 2004 · 302 citations

Life Sciences, Neurology, Meta-analysis +9

Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite

Laura J. Balcer, Monika Baier, J. A. Cohen et al. · Neurology · 2003 · 192 citations

Medicine, Neurology, Ophthalmology +17

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Andrew Goodman, Ted R. Brown, J. A. Cohen et al. · Neurology · 2008 · 178 citations

Education, Pharmacotherapy, Clinical Pharmacology +16